Historical Stock Data
|52 Week High|
|52 Week Low|
A Brief Recap of the Abbott–Alere Deal Developments
Dec 9, 2016 | 2:54 pm 1 Article Series
Three months after announcing a $5.8 billion deal in which Abbott Laboratories (ABT) would buy Alere (ALR), Alere rejected Abbott's $50 million offer to end the deal. On December 7, Abbott sued Alere to terminate the deal.